Literature DB >> 29860581

Research Progress on Reversing Multidrug Resistance in Tumors by Using Chinese Medicine.

Huan-Dong Zhao1,2, Hong-Juan Xie3, Jian Li1, Cai-Ping Ren4, Yu-Xiang Chen5.   

Abstract

Multidrug resistance (MDR) is a major cause of cancer chemotherapy failure, and it is important to develop suitable reversal agents to overcome MDR. A majority of chemical reversal agents have acceptable reversal effects. However, the toxicity and adverse reactions associated with these agents restricts their clinical use. Chinese medicines (CMs) have lower toxicities and adverse reactions and are associated with multiple components, multiple targets and reduced toxicity. CMs have several advantages and could reverse MDR, decrease drug dosage, enhance patient compliance and increase efficacy. This review summarizes the current progress of CM reversal agents..

Entities:  

Keywords:  Chinese medicine; multidrug resistance; reversal agents; tumor

Mesh:

Substances:

Year:  2018        PMID: 29860581     DOI: 10.1007/s11655-018-2910-1

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  60 in total

1.  Ginsenoside Rh2 differentially mediates microRNA expression to prevent chemoresistance of breast cancer.

Authors:  Xu Wen; He-Da Zhang; Li Zhao; Yu-Feng Yao; Jian-Hua Zhao; Jin-Hai Tang
Journal:  Asian Pac J Cancer Prev       Date:  2015

2.  A dynamic study on reversal of multidrug resistance by ginsenoside Rh₂ in adriamycin-resistant human breast cancer MCF-7 cells.

Authors:  Bei Zhou; Xiuli Xiao; Lili Xu; Lian Zhu; Liang Tan; Hao Tang; Youyu Zhang; Qingji Xie; Shouzhuo Yao
Journal:  Talanta       Date:  2011-11-02       Impact factor: 6.057

3.  Evaluation of ameliorative effect of curcumin on imidacloprid-induced male reproductive toxicity in wistar rats.

Authors:  Milindmitra Lonare; Manoj Kumar; Sachin Raut; Amar More; Sagar Doltade; Prarabdh Badgujar; Avinash Telang
Journal:  Environ Toxicol       Date:  2015-03-10       Impact factor: 4.119

4.  Resveratrol Increases Anti-Proliferative Activity of Bestatin Through Downregulating P-Glycoprotein Expression Via Inhibiting PI3K/Akt/mTOR Pathway in K562/ADR Cells.

Authors:  Li Wang; Changyuan Wang; Yongming Jia; Zhihao Liu; Xiaohong Shu; Kexin Liu
Journal:  J Cell Biochem       Date:  2015-11-30       Impact factor: 4.429

5.  Design and synthesis of novel tetrandrine derivatives as potential anti-tumor agents against human hepatocellular carcinoma.

Authors:  Junjie Lan; Ning Wang; Lan Huang; Yazhou Liu; Xiaopan Ma; Huayong Lou; Chao Chen; Yibin Feng; Weidong Pan
Journal:  Eur J Med Chem       Date:  2017-01-07       Impact factor: 6.514

6.  Polymeric nanoassemblies entrapping curcumin overcome multidrug resistance in ovarian cancer.

Authors:  Qiheng Gou; Lei Liu; Chunting Wang; Qinjie Wu; Lu Sun; Xi Yang; Yuxin Xie; Ping Li; Changyang Gong
Journal:  Colloids Surf B Biointerfaces       Date:  2014-12-13       Impact factor: 5.268

Review 7.  ABC multidrug transporters: structure, function and role in chemoresistance.

Authors:  Frances J Sharom
Journal:  Pharmacogenomics       Date:  2008-01       Impact factor: 2.533

Review 8.  Compounds from Chinese herbal medicines as reversal agents for P-glycoprotein-mediated multidrug resistance in tumours.

Authors:  C Li; B-Q Sun; X-D Gai
Journal:  Clin Transl Oncol       Date:  2014-03-19       Impact factor: 3.405

9.  Combined therapy with EGFR TKI and gambogic acid for overcoming resistance in EGFR-T790M mutant lung cancer.

Authors:  Chengde Wang; Wei Wang; Chaoyang Wang; Yijun Tang; Hui Tian
Journal:  Oncol Lett       Date:  2015-08-12       Impact factor: 2.967

10.  Effect of curcumin on human colon cancer multidrug resistance in vitro and in vivo.

Authors:  Wei-Dong Lu; Yong Qin; Chuang Yang; Lei Li; Zhong-Xue Fu
Journal:  Clinics (Sao Paulo)       Date:  2013-05       Impact factor: 2.365

View more
  5 in total

Review 1.  Combating Drug Resistance in Colorectal Cancer Using Herbal Medicines.

Authors:  Ga-Young Lee; Jin-Seok Lee; Chang-Gue Son; Nam-Hun Lee
Journal:  Chin J Integr Med       Date:  2020-08-01       Impact factor: 1.978

2.  Network Pharmacology-Based Study on the Active Component and Mechanism of the Anti-Non-Invasive and Invasive Bladder Urothelial Carcinoma Effects of Zhuling Jisheng Decoction.

Authors:  Chenyu Ma; Jianlong Wang; Na Zhao; Zhenya Pan; Yi Lu; Miao Cheng; Min Deng
Journal:  Comput Math Methods Med       Date:  2021-12-31       Impact factor: 2.238

Review 3.  Oplopanax horridus: Phytochemistry and Pharmacological Diversity and Structure-Activity Relationship on Anticancer Effects.

Authors:  Kai Wu; Chong-Zhi Wang; Chun-Su Yuan; Wei-Hua Huang
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-13       Impact factor: 2.629

Review 4.  Microfluidization trends in the development of nanodelivery systems and applications in chronic disease treatments.

Authors:  Palanivel Ganesan; Govindarajan Karthivashan; Shin Young Park; Joonsoo Kim; Dong-Kug Choi
Journal:  Int J Nanomedicine       Date:  2018-10-09

5.  Curcumol increases the sensitivity of colon cancer to 5-FU by regulating Wnt/β-catenin signaling.

Authors:  Jinfeng Gao; Daorong Hou; Ping Hu; Guoxin Mao
Journal:  Transl Cancer Res       Date:  2021-05       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.